Camp4 Therapeutics CORP S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
CAMP4 Therapeutics is seeking to raise capital through an initial public offering to advance its regulatory RNA-based therapeutics pipeline.
NASDAQ
CAMP4 Therapeutics is planning an initial public offering to fund its regulatory RNA-based therapeutics development.
NASDAQ
CAMP4 Therapeutics is seeking to go public to fund the development of its regulatory RNA-based therapeutics, initially targeting urea cycle disorders and SYNGAP1-related disorders.